cbdMD, Inc. (YCBD) Cash Flow Statement
Where YCBD’s cash came from and went, FY2025
September 30, 2025 · U.S. dollars- Cash from operations
- −$1.5M
- Capital expenditures
- $184,175 1.0% of revenue
- Free cash flow
- −$1.6M −8.5% margin
- Returned to shareholders
- —
- Change in cash
- −$191,311 cash at year-end $2.3M
Cash from operations
−$1.5M
Capital expenditures
−$184,175
Shares issued
+$1.4M
Change in cash
−$191,311
Drawn to scale: where the cash came from and how it was used. Hover for values.
YCBD operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
YCBD cash flow trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$2.9MFY2016 | −$1.5MFY2025 | — | |
| Capital expenditures | $127,259FY2016 | $184,175FY2025 | +4.2%/yr | |
| Free cash flow | −$3.0MFY2016 | −$1.6MFY2025 | — | |
| Free cash flow margin | −148.9%FY2016 | −8.5%FY2025 | +140.3 pts | |
| Operating cash flow / net income | −88.70FY2018 | −0.85FY2020 | +87.85 | |
| Stock-based compensation | $11,450FY2016 | $14,121FY2025 | +2.4%/yr | |
| Dividends paid | $29,180FY2017 | $0FY2024 | −100.0% | |
| Share buybacks (net) | $0FY2016 | $0FY2023 | — | |
| Capex / revenue | 6.3%FY2016 | 1.0%FY2025 | −5.3 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
YCBD cash flow by activity
OperatingInvestingFinancingChange in cash
YCBD net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
YCBD cash flow statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$2.04B | −$3.7M | −$22.9M | −$70.1M | −$23.4M | $12.6M | −$51.4M | $62,834 | −$1.4M | −$3.9M |
| Depreciation & amortization | $1.8M | $1.8M | $2.9M | $3.0M | $2.3M | $720,755 | $289,574 | $222,546 | $71,276 | $44,935 |
| Stock-based compensation | $14,121 | $16,900 | $342,868 | $928,825 | $2.9M | $2.0M | $2.7M | $678,731 | $212,933 | $11,450 |
| Change in working capital | −$2.0M | −$538,826 | $570,447 | −$2.8M | −$2.8M | −$184,512 | −$6.1M | −$4.2M | −$988,431 | $673,881 |
| Other non-cash items | $2.04B | $2.0M | $14.8M | $54.0M | $6.9M | −$25.8M | $39.1M | −$2.3M | −$239,451 | $268,750 |
| Cash from operating activities | −$1.5M | −$352,792 | −$4.3M | −$15.0M | −$14.1M | −$10.7M | −$15.4M | −$5.6M | −$2.3M | −$2.9M |
| Investing activities | ||||||||||
| Capital expenditures | −$184,175 | −$290,015 | −$297,549 | −$688,680 | −$2.3M | −$1.3M | −$1.2M | −$383,559 | −$7,967 | −$127,259 |
| Investments (net) | — | −$290,015 | $702,451 | −$688,680 | −$210,000 | −$250,000 | −$2.1M | −$683,559 | $152,310 | −$127,259 |
| Acquisitions & other investing | $3 | $290,015 | $297,549 | $688,680 | $0 | $0 | $1.2M | $383,559 | $7,967 | $127,259 |
| Cash from investing activities | −$184,172 | −$290,015 | $702,451 | −$688,680 | −$2.6M | −$1.6M | −$2.1M | −$683,559 | $152,310 | −$127,259 |
| Financing activities | ||||||||||
| Dividends paid | — | $0 | −$3.7M | −$4.0M | −$2.6M | −$366,850 | −$366,850 | −$366,850 | −$29,180 | — |
| Share repurchases & issuance (net) | — | — | $132,599 | — | −$30.8M | −$1.5M | $19.0M | $10.9M | $832,500 | $2.0M |
| Net borrowing (repayment) | $0 | $1.2M | −$132,599 | −$33,355 | −$151,551 | $1.5M | −$764,300 | −$764,300 | — | — |
| Shares issued | $1.4M | $50,001 | $2.5M | $15.1M | $30.9M | $21.2M | $19.0M | $10.9M | $0 | $0 |
| Other financing | $0 | $0 | −$132,599 | −$15.1M | $30.8M | $1.5M | −$19.0M | −$10.5M | $1.6M | $527,560 |
| Cash from financing activities | $1.4M | $1.3M | −$1.3M | −$4.0M | $28.2M | $22.4M | $17.9M | $10.3M | $2.4M | $2.5M |
| Summary | ||||||||||
| Net change in cash | −$191,311 | $654,693 | −$4.9M | −$19.7M | $11.6M | $10.1M | $407,413 | $4.0M | $249,988 | −$512,203 |
| Cash at end of period | $2.3M | $2.5M | $1.8M | $6.7M | $26.4M | $14.8M | $4.7M | $4.3M | $284,246 | $34,258 |
| Free cash flow | −$1.6M | −$642,807 | −$4.6M | −$15.7M | −$16.4M | −$12.0M | −$16.6M | −$6.0M | −$2.3M | −$3.0M |
| Free cash flow margin | −8.5% | −3.3% | −19.0% | −44.2% | −36.9% | −28.6% | −70.3% | −1,297.5% | −52.2% | −148.9% |
| Capex / revenue | 1.0% | 1.5% | 1.2% | 1.9% | 5.3% | 3.2% | 5.3% | 83.5% | 0.2% | 6.3% |
| Operating cash flow / net income | — | — | — | — | — | −0.85 | — | −88.70 | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$1.13B | −$797,978 | −$283.1M | −$679,968 | −$895,272 | −$465.7M | $15,095 | −$152,799 | $459,738 | −$3.0M | −$996,501 | −$15.9M |
| Depreciation & amortization | $441,118 | $422,738 | $416,630 | $432,537 | $448,513 | $575,734 | $339,138 | $76,005 | $585,579 | $584,707 | $574,165 | $954,847 |
| Stock-based compensation | $65.2M | $294,445 | $2,505 | $10,428 | $825 | $861 | $2,007 | $4,808 | $8,248 | $1,383 | $106,888 | $106,888 |
| Change in working capital | $1.07B | −$641,703 | −$948,468 | −$756,720 | −$258,266 | −$287,898 | −$666,476 | −$1.2M | $90,720 | $279,233 | $377,242 | $487,071 |
| Other non-cash items | −$455.4M | −$2 | $282.8M | $752,974 | $0 | $465.2M | −$7,713 | $1.5M | −$854,506 | $1.4M | −$174,179 | $14.1M |
| Cash from operating activities | −$442.2M | −$722,500 | −$812,464 | −$240,749 | −$704,200 | −$189,477 | −$317,949 | $167,377 | $289,779 | −$704,068 | −$112,385 | −$263,501 |
| Investing activities | ||||||||||||
| Capital expenditures | −$18.1M | −$5,750 | −$164.8M | −$2,804 | −$1,475 | −$15,503 | −$164,387 | −$110,000 | −$1 | −$4,620 | −$184,635 | −$120,180 |
| Investments (net) | — | — | — | — | −$1,475 | −$15,506 | −$164,387 | −$110,000 | $0 | $4,620 | −$184,635 | −$120,180 |
| Acquisitions & other investing | $0 | $56,429 | $164.6M | $0 | $1,475 | $15,503 | $164,387 | — | — | $4,620 | $184,635 | — |
| Cash from investing activities | −$18.1M | $50,679 | −$164,802 | −$2,804 | −$1,475 | −$15,506 | −$164,387 | — | — | $4,620 | −$184,635 | — |
| Financing activities | ||||||||||||
| Dividends paid | −$120.3M | — | — | — | — | — | — | $0 | $0 | $0 | −$666,997 | −$666,997 |
| Share repurchases & issuance (net) | — | — | — | — | — | — | — | — | — | — | — | $2,454 |
| Net borrowing (repayment) | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Shares issued | $0 | $0 | $2.1M | $1.4M | $0 | $0 | $0 | $1 | $0 | $0 | $0 | $4,253 |
| Other financing | $60.6M | −$77,869 | $0 | $0 | $0 | $0 | $1 | $0 | $0 | $1.3M | $664,496 | −$4,908 |
| Cash from financing activities | −$59.7M | −$77,869 | $2.1M | $1.4M | $0 | $0 | $1 | $1 | $0 | $1.3M | −$2,501 | −$665,198 |
| Summary | ||||||||||||
| Net change in cash | −$519.9M | −$749,690 | $1.1M | $1.2M | −$705,675 | −$204,983 | −$482,336 | $57,378 | $289,779 | $600,552 | −$293,016 | −$1.0M |
| Cash at end of period | $2.12B | $2.6M | $3.4M | $2.3M | $1.1M | $1.8M | $2.0M | $2.5M | $2.4M | $2.1M | $1.5M | $1.8M |
| Free cash flow | −$460.2M | −$728,250 | −$164.8M | −$243,553 | −$705,675 | −$204,980 | −$482,336 | $57,377 | $289,779 | −$699,448 | −$297,020 | −$383,681 |
| Free cash flow margin | −8,286.7% | −12.9% | −3,284.9% | −5.2% | −15.3% | −4.3% | −9.4% | 1.3% | 5.6% | −16.0% | −5.5% | −6.7% |
| Capex / revenue | 325.3% | 0.1% | 3,284.9% | 0.1% | 0.0% | 0.3% | 3.2% | 2.4% | 0.0% | 0.1% | 3.4% | 2.1% |
| Operating cash flow / net income | — | — | — | — | — | — | −21.06 | — | 0.63 | — | — | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
YCBD cash generation
In fiscal 2025 (ended September 30, 2025), cbdMD generated -$1.5 million of cash from operations and spent $0.2 million on capital expenditures, leaving free cash flow of -$1.6 million, −8.5% of revenue. Cash and equivalents fell by $0.2 million over the year.
Related: YCBD income statement, YCBD balance sheet. See the YCBD stock overview for the latest quote and news.
YCBD cash flow FAQ
What is cbdMD's free cash flow?
cbdMD's free cash flow was -$1.6 million in fiscal 2025: -$1.5 million of operating cash flow minus $0.2 million of capital expenditures It was -$0.6 million a year earlier..
How much cash does cbdMD generate from operations?
cbdMD generated -$1.5 million of cash from operating activities in fiscal 2025.
How much does cbdMD spend on capital expenditures?
cbdMD spent $0.2 million on capital expenditures in fiscal 2025, 1.0% of revenue, compared with $0.3 million the year before.